Many clinical studies have demonstrated that the expression of Gal-9 has a close association with metastasis and recurrence in solid tumors, including melanoma [19], gastric cancer [20], hepatocellular cancer [21], lung cancer [22], and breast cancer [23]. Here, LGALS9 is linked to breast carcinoma.